Aims To analyse the safety and efficacy of direct oral anticoagulants (DOACs) in real-world
studies including atrial fibrillation (AF) patients. Methods and results Systematic review and …

Atrial fibrillation (AF) is the most common supraventricular arrhythmia associated with
increased cardiovascular and non-cardiovascular morbidity and mortality. As multiple factors …

Background An integrated care approach is recommended to optimize management of
patients with atrial fibrillation (AF). The impact of the Atrial fibrillation Better Care (ABC) …

Background Studies have shown that patients with non-valvular atrial fibrillation (NVAF) who
discontinue oral anticoagulants (OACs) are at higher risk of complications such as stroke …

Objectives: Atrial fibrillation (AF) is characterized by an oxidative imbalance, which is
associated with an increased risk of cardiovascular events (CVEs). It is unclear whether low …

The 2MACE score was specifically developed as a risk-stratification tool in atrial fibrillation
(AF) to predict cardiovascular outcomes. We evaluated the predictive ability of the 2MACE …

Atrial fibrillation (AF) and cancer are frequently coexisting in elderly patients. Pooled
metanalytic data on the impact of cancer on clinical outcomes in AF patients are lacking. We …

Objective Antithrombotic therapy in patients with nonvalvular atrial fibrillation (NVAF)
concomitant with the acute coronary syndrome (ACS) or underwent percutaneous coronary …

Background Arterial hypertension is the most common cardiovascular comorbidity in atrial
fibrillation (AF). Few studies investigated management strategies of hypertension in AF …

Whether there are differences in direct oral anticoagulants efficacy and safety in patients
with atrial fibrillation (AF) combined with hypertension is unclear. We therefore conducted a …